TechNewsPro_Masthead_2.jpg

The latest in NEWS, RESOURCES and JOBS

Lower the TCO of your legacy data wareho
Talend_Banner_728x90px_v1.jpg
  • Caspar James - Tech Journalist

BioNTech, creators of the Pfizer vaccine, plan to use tech used for Covid jabs, to fight cancer

Husband and wife team Ozlem Tureci and Ugur Sahin, co-founders of BioNTech, have spent twenty years searching for a method to trigger the body’s immune system to tackle tumours. The technology used on that research was then applied to working on the successful Pfizer Covid vaccine. It is thought that this same method can now be used to help fight tumours, by harnessing the body’s immune system.



With the global onslaught of the Covid-19 virus, the couple decided to apply their two decades of research, which they dubbed ‘Operation Lightspeed’ towards the new global pandemic threat. Within 11 month their vaccine had been given approval by the British government as one of two vaccines to help tackle Covid-19. This was to be the very first vaccine to come out the Mainz-based company and they had to conduct large scale clinical trails and then find a method to manufacture the vaccine in large quantities, to meet a global demand. Pfizer was then brought in, along with China’s Fosun Pharma, to bring in assets, capabilities and a geographical footprint which BioNTech did not have.


From the very onset, it was planned that any new vaccine they produced, would need pass any rigorous scrutiny of the regulators and with the help of BioNTech’s team of 60 staff from around the world, they were able to develop a vaccine that worked. No corners were cut in getting the vaccine approved in the race to find a workable vaccine. Even once a vaccine is approved, it will continue to be improved as screening in place around the world, assess how the vaccine is working and observations made in how effective it is in various worldwide locations.

Now that BioNTech’s vaccine has been approved, the value of the company has increased, enabling them to invest back into their original cancer research project to develop a new tool against cancer. The Pfizer vaccine uses a RNA or mRMA, which carries instructions into the body by making proteins that prime it to attack a specific virus. This principal can now be applied to trigger the immune system to take on tumours.

With the success of their Pfizer vaccine, BioNTech can now use the knowledge leant from the developing the corona virus vaccine, on finding a method of tackling tumours.

Element_300x600_June_2.jpg

LATEST RESOURCES

 

 

Parting the clouds. 

for greater security

Covid-19 has landed CSOs a unique opportunity to embrace web isolation.

Eliminate malware threats with zero trust 

Isolation-powered security provides full protection against email and Web based threats.

7 Customer Service Mistakes Companies Should Avoid Making

2020 was a tumultuous year but it did bring customer service back to the forefront of the business planning agenda for 2021. As you plan and prioritise your initiatives, it is important to avoid mistakes.

Integrating Compliance into Innovation: Taking Control Over Customer Communications

Compliance is one of those areas that is better off unnoticed. When compliance does get attention, it is usually because something has gone wrong and that is something that keeps executives up at night. It is easy to see why. 

Artificial Intelligence Based COVID Signature

Detection Software

The software takes the X-Rays and CT scans in digital format and analyses the X-Ray reports through uploading the images which is followed by detailed report about the patient suffering from COVID19 or similar ailments.

Six Steps to Drive Your

Process Center of Excellence to Success

Find out why yo need a center of excellence - and how save you time and money while improving experiences for both your customers and employees. 

Steps to Deliver Data You Can trust at the Speed of Business

Why trusted data is the key to digital transformation. Discover and cleanse your data. 

Organise data you can trust and empower people

Automate your data pipelines and enable data access.

2021 Threat Report 

Four Key Trends in the Cyber-Threat Landscape.

The security implications of remote working, SaaS takeover, rise of fearware, server side attacks, ransomware and Darktrace immune system.

Safe, inclusive communications for the University of Innsbruck

The open matrix is the foundation for secure, collaborative academic research and learning. Keen to support its learning culture, the university wanted to introduce a real time messaging system. 

Darktrace_Logo_Main.png
Element_Logo.jpg
eGain_logo.jpg
talend_Logo.png
MenloSecurity_Signature_Purple_RGB.jpg
MenloSecurity_Signature_Purple_RGB.jpg
nintex_logo.png
GMC_Software_Logo.jpg

    SUBSCRIBE

to our latest RESOURCES

to keep up to date with the

latest whitepapers

WP_GMC_Cover.jpg
WP_bold360_Cover.jpg